CHEBI:32020 - pitavastatin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name pitavastatin
ChEBI ID CHEBI:32020
Definition A dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C25H24FNO4
Net Charge 0
Average Mass 421.46080
Monoisotopic Mass 421.169
InChI InChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+/t18-,19-/m1/s1
InChIKey VGYFMXBACGZSIL-MCBHFWOFSA-N
SMILES O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O
Roles Classification
Chemical Role(s): antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.
(via statin )
Application(s): anticholesteremic drug
A substance used to lower plasma cholesterol levels.
(via statin )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing pitavastatin (CHEBI:32020) has role antioxidant (CHEBI:22586)
pitavastatin (CHEBI:32020) is a cyclopropanes (CHEBI:51454)
pitavastatin (CHEBI:32020) is a dihydroxy monocarboxylic acid (CHEBI:35972)
pitavastatin (CHEBI:32020) is a monofluorobenzenes (CHEBI:83575)
pitavastatin (CHEBI:32020) is a quinolines (CHEBI:26513)
pitavastatin (CHEBI:32020) is a statin (synthetic) (CHEBI:87635)
pitavastatin (CHEBI:32020) is conjugate acid of pitavastatin(1−) (CHEBI:71260)
Incoming pitavastatin(1−) (CHEBI:71260) is conjugate base of pitavastatin (CHEBI:32020)
IUPAC Name
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
INNs Sources
pitavastatia WHO MedNet
pitavastatin WHO MedNet
pitavastatine WHO MedNet
pitavastatinum WHO MedNet
Synonyms Sources
NK 104 ChemIDplus
NK-104 ChemIDplus
Database Links Databases
2214 DrugCentral
C13334 KEGG COMPOUND
EP2141155 Patent
HMDB0041991 HMDB
Pitavastatin Wikipedia
US2011269962 Patent
US2012016129 Patent
View more database links
Registry Numbers Types Sources
147511-69-1 CAS Registry Number ChemIDplus
7257773 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
21075465 PubMed citation Europe PMC
21585411 PubMed citation Europe PMC
21884024 PubMed citation Europe PMC
22053916 PubMed citation Europe PMC
22077103 PubMed citation Europe PMC
22133277 PubMed citation Europe PMC
22149769 PubMed citation Europe PMC
22268518 PubMed citation Europe PMC
22332608 PubMed citation Europe PMC
22345687 PubMed citation Europe PMC
22356292 PubMed citation Europe PMC
22361916 PubMed citation Europe PMC
22410289 PubMed citation Europe PMC
22472908 PubMed citation Europe PMC
22520230 PubMed citation Europe PMC
22627182 PubMed citation Europe PMC
22679249 PubMed citation Europe PMC
22807641 PubMed citation Europe PMC
22850760 PubMed citation Europe PMC
22878405 PubMed citation Europe PMC
22884685 PubMed citation Europe PMC
22948417 PubMed citation Europe PMC
23007012 PubMed citation Europe PMC
23161429 PubMed citation Europe PMC
Last Modified
22 February 2017